Announcement

Collapse
No announcement yet.

J Epilepsy Res . Anti-N-Methyl-D-Aspartate Receptor Encephalitis after BNT162b2 COVID-19 Vaccination

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • J Epilepsy Res . Anti-N-Methyl-D-Aspartate Receptor Encephalitis after BNT162b2 COVID-19 Vaccination


    J Epilepsy Res


    . 2022 Dec 30;12(2):71-73.
    doi: 10.14581/jer.22013. eCollection 2022 Dec.
    Anti-N-Methyl-D-Aspartate Receptor Encephalitis after BNT162b2 COVID-19 Vaccination


    Hyoung Cheol Lee 1 , Byung-Kun Kim 1 , Kyusik Kang 1 , Woong-Woo Lee 1 , Ilhan Yoo 1 , Yong Soo Kim 1 , Jung-Ju Lee 1



    Affiliations

    Abstract

    After the coronavirus disease 2019 (COVID-19) pandemic emerged, the development of vaccines was accelerated. Neurologic complications of COVID-19 vaccination had been reported, which included encephalitis. In this study, we report a very rare case of a female with anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma that would be triggered by BNT162b2 m-RNA COVID-19 vaccination.

    Keywords: COVID19 vaccine; Encephalitis; NMDA.

Working...
X